Matteo Gastaldi

Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study

Vera Bril, Artur Drużdż, Julian Großkreutz et al. · The Lancet Neurology · 2023 · 227 citations

Clinical Trials, Generalised Myasthenia Gravis, Pharmacotherapy +3

Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP

Andrea Cortese, Raffaella Lombardi, Chiara Briani et al. · Neurology Neuroimmunology & Neuroinflammation · 2019 · 170 citations · Full text

Combined central and peripheral demyelination: Clinical features, diagnostic findings, and treatment

Andrea Cortese, Diego Franciotta, Enrico Alfonsi et al. · Journal of the Neurological Sciences · 2016 · 79 citations

Peripheral Demyelination, Ophthalmology, Neurological Disorder +9

A single T cell epitope drives the neutralizing anti-drug antibody response to natalizumab in multiple sclerosis patients

Antonino Cassotta, Vincent Mikol, Thomas Bertrand et al. · Nature Medicine · 2019 · 70 citations

Multiple Sclerosis Patients, Allergy, Autoimmune Disease +10

Cell-based assays for the detection of MOG antibodies: a comparative study

Matteo Gastaldi, Silvia Scaranzin, Sven Jarius et al. · Journal of Neurology · 2020 · 70 citations · Full text

Immunocytochemical Technique, Bioanalysis, Immunology +10